CLC number:
On-line Access: 2021-11-16
Received: 2021-01-11
Revision Accepted: 2021-05-06
Crosschecked: 0000-00-00
Cited: 0
Clicked: 4403
Yi ZHAO, Benzheng ZHANG, Qianqian ZHANG, Xiaowei MA, Helin FENG. Tumor-associated macrophages in osteosarcoma[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2100029 @article{title="Tumor-associated macrophages in osteosarcoma", %0 Journal Article TY - JOUR
肿瘤相关巨噬细胞在骨肉瘤的研究进展关键词组: Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference[1]AlfrancaA, Martinez-CruzadoL, TorninJ, et al., 2015. Bone microenvironment signals in osteosarcoma development. Cell Mol Life Sci, 72(16):3097-3113. [2]BalanisN, CarlinCR, 2017. Stress-induced EGF receptor signaling through STAT3 and tumor progression in triple-negative breast cancer. Mol Cell Endocrinol, 451:24-30. [3]Bighetti-TrevisanRL, SousaLO, CastilhoRM, et al., 2019. Cancer stem cells: powerful targets to improve current anticancer therapeutics. Stem Cells Int, 2019:9618065. [4]BingleL, BrownNJ, LewisCE, 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol, 196(3):254-265. [5]Binnemars-PostmaK, BansalR, StormG, et al., 2018. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer. FASEB J, 32(2):969-978. [6]BrownHK, Tellez-GabrielM, HeymannD, 2017. Cancer stem cells in osteosarcoma. Cancer Lett, 386:189-195. [7]BuddinghEP, KuijjerML, DuimRAJ, et al., 2011. Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin Cancer Res, 17(8):2110-2119. [8]ChengDD, LiSJ, ZhuB, et al., 2018. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-Bad signaling. J Exp Clin Cancer Res, 37:50. [9]CorreI, VerrecchiaF, CrennV, et al., 2020. The osteosarcoma microenvironment: a complex but targetable ecosystem. Cells, 9(4):976. [10]DanieauG, MoriceS, RédiniF, et al., 2019. New insights about the Wnt/β-catenin signaling pathway in primary bone tumors and their microenvironment: a promising target to develop therapeutic strategies? Int J Mol Sci, 20(15):3751. [11]DumarsC, NgyuenJM, GaultierA, et al., 2016. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget, 7(48):78343-78354. [12]FanQM, JingYY, YuGF, et al., 2014. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett, 352(2):160-168. [13]GenselJC, ZhangB, 2015. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res, 1619:1-11. [14]GibbsCP, KukekovVG, ReithJD, et al., 2005. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 7(11):967-976. [15]HanQL, ShiHG, LiuF, 2016. CD163+ M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma. Int Immunopharmacol, 34:101-106. [16]HanY, GuoW, RenTT, et al., 2019. Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Lett, 440-441:116-125. [17]HeR, WuJX, ZhangY, et al., 2018. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma. Eur Rev Med Pharmacol Sci, 22(18):5857-5866. [18]HegabAE, OzakiM, KameyamaN, et al., 2019. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts. J Pathol, 249(2):193-205. [19]HeymannMF, LézotF, HeymannD, 2019. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. Cell Immunol, 343:103711. [20]HuHL, BaiHS, PanHX, 2015. Correlation between TAMs and proliferation and invasion of type I endometrial carcinoma. Asian Pac J Trop Med, 8(8):643-650. [21]InagakiY, HookwayE, WilliamsKA, et al., 2016. Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours. Clin Sarcoma Res, 6:13. [22]JayasingamSD, CitartanM, TangTH, et al., 2020. Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol, 9:1512. [23]JoyceJA, PollardJW, 2009. Microenvironmental regulation of metastasis. Nature Rev Cancer, 9(4):239-352. [24]KimuraY, SumiyoshiM, 2015. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells. Eur J Pharmacol, 746:115-125. [25]KimuraY, SumiyoshiM, 2016. Resveratrol prevents tumor growth and metastasis by inhibiting lymphangiogenesis and M2 macrophage activation and differentiation in tumor-associated macrophages. Nutr Cancer, 68(4):667-678. [26]KimuraY, SumiyoshiM, BabaK, 2016. Antitumor and antimetastatic activity of synthetic hydroxystilbenes through inhibition of lymphangiogenesis and M2 macrophage differentiation of tumor-associated macrophages. Anticancer Res, 36(1):137-148. [27]KlämbtC, 2000. EGF receptor signalling: the importance of presentation. Curr Biol, 10(10):R388-R391. [28]LeeCH, LiuSY, ChouKC, et al., 2014. Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway. Ann Surg Oncol, 21(3):1031-1037. [29]LewisCE, HughesR, 2007. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res, 9(3):209. [30]LiYS, LiuQ, TianJ, et al., 2019. Angiogenesis process in osteosarcoma: an updated perspective of pathophysiology and therapeutics. Am J Med Sci, 357(4):280-288. [31]LimB, WoodwardWA, WangXP, et al., 2018. Inflammatory breast cancer biology: the tumour microenvironment is key. Nat Rev Cancer, 18(8):485-499. [32]LinXR, ChenLJ, YaoYD, et al., 2015. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis. Oncotarget, 6(24):20485-20499. [33]LiuF, SunJ, YuW, et al., 2020. Quantum dot-pulsed dendritic cell vaccines plus macrophage polarization for amplified cancer immunotherapy. Biomaterials, 242:119928. [34]Lopez-YrigoyenM, CassettaL, PollardJW, 2020. Macrophage targeting in cancer. Ann N Y Acad Sci, 242:119928. [35]MantovaniA, MarchesiF, MalesciA, et al., 2017. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol, 14(7):399-416. [36]MurdochC, MuthanaM, CoffeltSB, et al., 2008. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer, 8(8):618-631. [37]NgambenjawongC, GustafsonHH, PunSH, 2017. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev, 114:206-221. [38]OsinskyS, BubnovskayaL, GanusevichI, et al., 2011. Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival. Clin Transl Oncol, 13(2):133-138. [39]PahlJHW, KwappenbergKMC, VarypatakiEM, et al., 2014. Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ. J Exp Clin Cancer Res, 33:27. [40]PerryCJ, Muñoz-RojasAR, MeethKM, et al., 2018. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med, 215(3):877-893. [41]PetersonTE, KirkpatrickND, HuangYH, et al., 2016. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. Proc Natl Acad Sci USA, 113(16): 4470-4475. [42]PunzoF, BelliniG, TortoraC, et al., 2020. Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells. Oncotarget, 11(7):687-698. [43]RahmaOE, HodiFS, 2019. The intersection between tumor angiogenesis and immune suppression. Clin Cancer Res, 25(18):5449-5457. [44]SégalinyAI, MohamadiA, DizierB, et al., 2015. Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. Int J Cancer, 137(1):73-85. [45]ShaoXJ, XiangSF, ChenYQ, et al., 2019. Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells. Acta Pharmacol Sin, 40(10):1343-1350. [46]TalukdarS, EmdadL, DasSK, et al., 2016. Evolving strategies for therapeutically targeting cancer stem cells. Adv Cancer Res, 131:159-191. [47]TiainenS, MasarwahA, OikariS, et al., 2020. Tumor microenvironment and breast cancer survival: combined effects of breast fat, M2 macrophages and hyaluronan create a dismal prognosis. Breast Cancer Res Treat, 179(3):565-575. [48]TianZQ, HouXJ, LiuWT, et al., 2019. Macrophages and hepatocellular carcinoma. Cell Biosci, 9:79. [49]UeharaT, EikawaS, NishidaM, et al., 2019. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects. Int Immunol, 31(4):187-198. [50]WanSS, ZhaoED, KryczekI, et al., 2014. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology, 147(6):1393-1404. [51]WernoC, MenradH, WeigertA, et al., 2010. Knockout of HIF-1α in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis, 31(10):1863-1872. [52]WhelanJS, DavisLE, 2018. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol, 36(2):188-193. [53]WuH, XuJB, HeYL, et al., 2012. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol, 106(4):462-468. [54]XiaoQ, ZhangXP, WuYY, et al., 2014. Inhibition of macrophage polarization prohibits growth of human osteosarcoma. Tumour Biol, 35(8):7611-7616. [55]XuanWJ, QuQ, ZhengB, et al., 2015. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukocyte Biol, 97(1):61-69. [56]YanGN, LvYF, GuoQN, 2016. Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets. Cancer Lett, 370(2):268-274. [57]YangCX, HeLY, HePQ, et al., 2015. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway. Med Oncol, 32(2):14. [58]YangD, LiuKY, FanL, et al., 2020. LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-like polarization of tumor-associated macrophages of CPEB4. Cancer Lett, 473:33-49. [59]YinSC, HuangJY, LiZ, et al., 2017. The prognostic and clinicopathological significance of tumor-associated macrophages in patients with gastric cancer: a meta-analysis. PLoS ONE, 12(1):e0170042. [60]ZhangQW, LiuL, GongCY, et al., 2012. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE, 7(12):e50946. [61]ZhaoXX, QuJK, SunYC, et al., 2017. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget, 8(18):30576-30586. [62]ZhouQ, XianM, XiangSF, et al., 2017. All-trans retinoic acid prevents osteosarcoma metastasis by inhibiting M2 polarization of tumor-associated macrophages. Cancer Immunol Res, 5(7):547-559. Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou
310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn Copyright © 2000 - 2024 Journal of Zhejiang University-SCIENCE |
Open peer comments: Debate/Discuss/Question/Opinion
<1>